[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"stroke-gait-rehabilitation\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:stroke-gait-rehabilitation":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,9,0,[8,47,76,105,130,152,177,201,226],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":30,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":46},"100642886","impact-of-vns-with-rehab-on-gait-post-stroke-100642886",false,"NCT07643337","Impact of VNS With Rehab on Gait Post-Stroke","The Impact of Vagus Nerve Stimulation Paired With Rehabilitation on Lower Limb and Gait Functions After Ischemic Stroke","Inclusion Criteria:\n\n* Approved for Vagus Nerve Stimulation (VNS) and rehabilitation therapy\n* ≥22 years and ≤ 80 years\n* Only patients who elect to undergo VNS therapy for stroke-related upper limb deficits\n* Residual active movement in the affected limb's thumb and other 2 fingers\n* Stroke-related deficits in the lower limbs and gait with a Functional Ambulation Category (FAC) ≥3\n* Able to follow simple instructions and independently walk short distances with or without external support or leg orthoses, but without manual contact with another person\n\nExclusion Criteria:\n\n* Intact lower limb functions (Fugl-Meyer score=34)\n* Not a candidate for VNS therapy according to FDA guidelines\n* Pregnant patients","ALL","22 Years","80 Years",{"count":20,"type":21},24,"ESTIMATED","INTERVENTIONAL",[24],"NA","This is a prospective, double-blinded, randomized controlled study to evaluate the impact of Vagus Nerve Stimulation (VNS) therapy on lower limb function.",[27,28,29],"Upper Limb Deficit","Stroke Gait Rehabilitation","Stroke",[31,32,33],"vagus nerve stimulation","stroke rehabilitation","stroke related upper limb deficit","RECRUITING","2026-06-08",{"date":37,"type":38},"2026-06-11","ACTUAL",{"date":40,"type":21},"2026-06",{"date":42,"type":21},"2028-02-23",{"name":44,"class":45},"State University of New York at Buffalo","OTHER",1,{"id":48,"slug":49,"hasResults":11,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":4,"eligibilityCriteria":53,"healthyVolunteers":11,"sex":16,"minAge":54,"maxAge":55,"enrollmentInfo":56,"targetDuration":4,"studyType":22,"phases":58,"briefSummary":59,"conditions":60,"keywords":61,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":70,"completionDateStruct":71,"leadSponsor":73,"locationsCount":75},"100596155","mint-conditioning-to-improve-gait-100596155","NCT07041775","MINT Conditioning to Improve Gait","MINT Conditioning to Improve Post-stroke Gait","Inclusion Criteria:\n\n* Age at enrollment is 18 to 85\n* Leg impairment from unilateral stroke at least 6 months prior to screening\n* Severe to moderate gait impairment (ambulatory with a maximum walking speed of 0.8 m\u002Fs, i.e., half of normal speed)\n* Able to stand without assistance\n* Clinically observable gait asymmetry\n* Abnormal co-activation between adductor magnus and rectus femoris (R greater than or equal to 0.5)\n\nExclusion Criteria:\n\n* Cognitive impairment with at least moderately impaired attention on digit-span test, or unable to follow instructions of the MINT task\n* Visual impairment (such as hemianopia) preventing sufficient perception of the screen to play the games\n* Anesthesia or severe neglect in the affected leg, or visual hemineglect (score of 2 on the NIH Stroke Scale Extinction and Inattention subtest) that impairs ability to play the games\n* Participation in another study on the affected leg, or any pharmacological study, within 6 weeks of enrollment\n* Inability to understand or follow commands in English due to aphasia or other reason that makes it impossible to perform the training\n* Diffuse or multifocal infarcts\n* Substantial leg or other pain preventing participation for 60 minutes a day\n* Spasticity treatment (pharmacological or Botox) on the affected leg within past 3 months\n* Severe osteoporosis causing hip or other fractures\n* History of multiple falls within the last year, use of walker for balance, or falling during stance while in the lab in the first session.\n* Contracture limiting the range of motion of the leg\n* Current pregnancy\n* From the TMS portion of the study only: History of epilepsy in adulthood requiring antiseizure medications; recent\u002Fcurrent alcoholism or benzodiazepine\u002Fbarbiturate abuse or recent history of alcohol\u002Fbenzodiazepine\u002Fbarbiturate withdrawal, recent history of cocaine or amphetamine use, skull fractures or skull deficits, concussion within the last 6 months, unexplained recurring headaches, vagus nerve stimulator, cochlear implant, deep brain stimulator, intracranial\u002Fcarotid stents, cardiac pacemaker\u002FAICD.","18 Years","85 Years",{"count":57,"type":21},72,[24],"This study will test the ability of myoelectric interface for neurorehabilitation (MINT) training to improve walking function.",[29,28],[62,63,64,65,66,67],"Stroke rehabilitation","Leg impairment","Walking","Rehabilitation gaming","Muscle biofeedback","Myoelectric interface","2026-06-04",{"date":35,"type":38},{"date":68,"type":38},{"date":72,"type":21},"2030-03",{"name":74,"class":45},"Northwestern University",2,{"id":77,"slug":78,"hasResults":11,"nctId":79,"briefTitle":80,"officialTitle":81,"acronym":4,"eligibilityCriteria":82,"healthyVolunteers":11,"sex":16,"minAge":54,"maxAge":4,"enrollmentInfo":83,"targetDuration":4,"studyType":22,"phases":84,"briefSummary":86,"conditions":87,"keywords":90,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":99,"completionDateStruct":101,"leadSponsor":103,"locationsCount":46},"100629016","phase-1-phase-i-split-belt-treadmill-dosing-for-subacute-stroke-100629016","NCT07469163","Phase I Split-Belt Treadmill Dosing for Subacute Stroke","NeuroRecoVR: Phase I Split-Belt Treadmill Dosing for Subacute Stroke","Inclusion Criteria:\n\n* Ischemic or hemorrhagic stroke survivors\n* First stroke\n* Over 18 years old\n* Between one week and three months post-stroke\n* can understand task instructions.\n\nExclusion Criteria:\n\n* History of significant neurological diseases (e.g. Multiple Sclerosis, Parkinson's disease)\n* Orthopedic issues in lower extremities (e.g. severe knee Osteoarthritis)\n* Excessive pain preventing participants from participating in treadmill-based activities\n* Cerebellar stroke\n* Body weight more than 560 lbs (this exceeds the weight limit of the support harness)",{"count":57,"type":21},[85],"PHASE1","After experiencing a stroke, many individuals encounter difficulties with walking and balance, which can significantly impact their independence. Recent studies have indicated that split-belt treadmill (SBT) training is effective for improving gait metrics, including walking speed and step length asymmetry. The SBT allows each leg to move at different speeds, which has been shown to help chronic stroke survivors learn to walk more symmetrically. However, there is limited knowledge about the dose participants should receive and the safety of SBT training in the early stages of recovery, which is a crucial period for rehabilitation. To address this gap, we are evaluating an innovative SBT with virtual reality (VR) features at the Foothills Medical Center. Our objective is to conduct a study to determine the amount of SBT training patients can tolerate in a day. In this study, stroke survivors will engage in a series of walking exercises on the SBT. We will escalate the duration of SBT walking until participants reach a point where they can no longer continue due to dose-limiting criteria such as fatigue or discomfort. The findings from this initial phase will guide future larger trials to explore the effectiveness of this training method. Ultimately, we aspire to improve rehabilitation strategies for stroke survivors, assisting them in regaining mobility and enhancing their quality of life more effectively.",[88,29,89,28],"Subacute Stroke","Stroke (Subacute)",[91,92,93,94,95],"stroke","subacute stroke","split belt treadmill","gait rehabilitation","stroke recovery","2026-03-09",{"date":98,"type":38},"2026-03-13",{"date":100,"type":38},"2026-03-01",{"date":102,"type":21},"2026-08-31",{"name":104,"class":45},"University of Calgary",{"id":106,"slug":107,"hasResults":11,"nctId":108,"briefTitle":109,"officialTitle":109,"acronym":4,"eligibilityCriteria":110,"healthyVolunteers":11,"sex":16,"minAge":54,"maxAge":111,"enrollmentInfo":112,"targetDuration":4,"studyType":22,"phases":114,"briefSummary":115,"conditions":116,"keywords":117,"overallStatus":120,"whyStopped":4,"lastUpdateSubmitDate":121,"lastUpdatePostDateStruct":122,"startDateStruct":124,"completionDateStruct":126,"leadSponsor":128,"locationsCount":4},"100614964","the-effect-of-whole-body-vibration-therapy-following-botulinum-toxin-a-injection-on-spasticity-and-balance-in-stroke-patients-100614964","NCT07286435","The Effect of Whole-Body Vibration Therapy Following Botulinum Toxin A Injection on Spasticity and Balance in Stroke Patients","Inclusion criteria:\n\n* Participants with unilateral hemiparesis due to hemorrhage or infarction\n* Participants aged 18-75 years\n* Participants with MAS ≥2 spasticity in the ankle\n* Participants with a Mini-Mental State Examination (MMSE) score of 24, indicating preserved cognitive and communication abilities\n* Participants who can walk at least 100 meters with or without assistive devices\n* Participants without joint contractures and with sufficient motor control to perform functional walking tests\n* Participants who have not previously undergone vibration therapy\n\nExclusion Criteria:\n\n* History of neurological disease (such as polyneuropathy or motor neuron diseases) other than a history of existing stroke\n* History of recent fracture in the lower extremity\n* Severe degenerative joint disease\n* History of implants in the lower extremity or spine\n* History of cardiac pacemakers\n* Presence of uncontrolled hypertension and uncontrolled diabetes\n* History of recent thromboembolism or infection\n* Participants whose antispasmodic medication regimen was changed within 1 month prior to starting treatment","75 Years",{"count":113,"type":21},50,[24],"The purpose of this clinical study is to evaluate the effect of Whole Body Vibration (WBV) therapy, applied two weeks after botulinum toxin type A (BoNT-A) injection, on spasticity and balance parameters in individuals with stroke who have ankle spasticity. The main questions it aims to answer are: Adjuvant WBV therapy administered after BoNT-A injection;\n\n* Does it effectively improve spasticity?\n* Is it an effective intervention for balance and walking functions? Researchers will compare the application of WBV to a placebo application (a vibration-free application) to evaluate the effect of adjuvant WBV therapy administered after BoNT-A injection on ankle spasticity, balance, and walking function in individuals with stroke.",[28],[118,119],"stroke, whole body vibration, spasticity, balance","gait","NOT_YET_RECRUITING","2025-12-02",{"date":123,"type":38},"2025-12-16",{"date":125,"type":21},"2025-12",{"date":127,"type":21},"2026-09",{"name":129,"class":45},"Uludag University",{"id":131,"slug":132,"hasResults":11,"nctId":133,"briefTitle":134,"officialTitle":135,"acronym":4,"eligibilityCriteria":136,"healthyVolunteers":11,"sex":16,"minAge":137,"maxAge":18,"enrollmentInfo":138,"targetDuration":4,"studyType":22,"phases":140,"briefSummary":141,"conditions":142,"keywords":4,"overallStatus":120,"whyStopped":4,"lastUpdateSubmitDate":143,"lastUpdatePostDateStruct":144,"startDateStruct":146,"completionDateStruct":148,"leadSponsor":150,"locationsCount":4},"100607740","effects-of-kinesio-taping-in-subacute-stroke-patients-100607740","NCT07192484","Effects of Kinesio Taping in Subacute Stroke Patients","Effects of Kinesio Taping on Gait Ability, Balance, and Neuromuscular Functions in Subacute Stroke Patients With Foot Drop","Inclusion Criteria:\n\n* Age between 20 and 80 years;\n* First unilateral stroke;\n* Stroke onset between at least 1 week and 1 year;\n* Ability to continuously walk 10 meters with or without assistive devices;\n* Presence of foot drop on the affected side during the swing phase due to insufficient ankle dorsiflexion;\n* Brunnstrom stage of the affected lower limb ≥ 3;\n* Presence of mild spasticity in the affected ankle plantar flexors, with a Modified Ashworth Scale score ≤ 2;\n* Ability to follow simple commands\n\nExclusion Criteria:\n\n* Other neurological disorders or unstable medical conditions;\n* Skin allergies that interfere with the use of tape;\n* Visual field defects;\n* Cognitive impairment, defined as a Mini-Mental State Examination (MMSE) score \\\u003C 24;\n* Pusher syndrome;\n* Ankle contracture;\n* Hemispatial neglect;\n* Poorly controlled hypertension or cardiovascular disease;\n* Any other disease, apart from stroke, that may affect balance or gait.","20 Years",{"count":139,"type":21},60,[24],"A study was designed to investigate the effects of KT on gait ability, balance, and neuromuscular functions in subacute stroke patients with foot drop. The study aims to evaluate the immediate and short-term effects of KT on gait ability, balance, and neuromuscular function in subacute stroke patients with foot drop. A total of 60 participants will be recruited and randomly assigned to either a control group (conventional physical therapy) or an experimental group (receiving additional KT). Both groups will receive 30 minutes of daily physical therapy. The experimental group will undergo an initial assessment before KT application, which includes (1) activation of the dorsiflexor muscles, (2) reduction of plantar flexor spasticity, and (3) stabilization of the ankle in an everted position. After taping, a second assessment will be conducted immediately, and the tape will stay applied to patient's limb for two days, followed by a third assessment. The control group will be assessed only before the intervention and after two days. Primary outcome measures include gait ability (10-meter walk test, laboratory gait parameters, and joint angles and electromyographic activity during walking). Secondary outcomes include balance (Functional reach test, Timed Up and Go test, and Activities-specific Balance Confidence Scale) and neuromuscular function assessments (muscle strength, joint range of motion, spasticity, and proprioception). This project aims to establish and validate a clinically applicable and effective KT protocol as an adjunctive gait training method for subacute stroke patients with foot drop. By enhancing independent and safe walking, this intervention may facilitate the early return to normal daily activities for stroke survivors.",[28],"2025-09-17",{"date":145,"type":38},"2025-09-25",{"date":147,"type":21},"2025-09-15",{"date":149,"type":21},"2026-12-31",{"name":151,"class":45},"Fooyin University",{"id":153,"slug":154,"hasResults":11,"nctId":155,"briefTitle":156,"officialTitle":157,"acronym":4,"eligibilityCriteria":158,"healthyVolunteers":11,"sex":16,"minAge":159,"maxAge":111,"enrollmentInfo":160,"targetDuration":4,"studyType":22,"phases":162,"briefSummary":163,"conditions":164,"keywords":166,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":169,"lastUpdatePostDateStruct":170,"startDateStruct":171,"completionDateStruct":173,"leadSponsor":175,"locationsCount":46},"100583619","individualized-exercise-prescription-with-a-data-driven-approach-in-individuals-with-stroke-100583619","NCT06878677","Individualized Exercise Prescription With a Data-driven Approach in Individuals With Stroke","Individualized Exercise Prescription With a Data-driven Approach in Individuals With Stroke - A Feasible Study","Inclusion Criteria:\n\n* between 45 and 75 years old;\n* have received a diagnosis of stroke more than six months earlier;\n* able to walk 10 m independently;\n* able to score at least 6 of 10 on the Abbreviated Mental Test;\n* able to follow instructions and give informed consent.\n\nExclusion Criteria:\n\n* any existing medical condition such as uncontrolled hypertension that hindered training or assessment;\n* unable to offer consent due to impaired cognitive function.","45 Years",{"count":161,"type":21},52,[24],"The goal of this clinical trial is to evaluate if the exercised via data-driven approach is effective in enhance the gait pattern in people with stroke. It will reduce burdun of patient consultations for clinicians in reality.The main questions it aims to answer are:\n\nDoes individualized exercise training programmes via data-driven approach could improve gait patterns in individuals with chronic stroke? Does individualized exercise training programmes via data-driven approach could improve improve motor recovery, motor functions (including gait speed and balance performance), and community integration in individuals with chronic stroke?\n\nParticipants will:\n\nUndergo 12 supervised-exercise (training sessions (60 minutes, two times a week, for six weeks), Participants will receive a data-driven exercise prescription or conventional exercise prescription which consists of 5 different exercises.\n\nThey will be assessed on Baseline assessment before training (A0); after six sessions (A1); after 12 sessions (A2); and three months after training (A3).",[28,165,29],"Stroke Patients",[91,167,119,168],"lower extremities","rehabilitation","2025-09-08",{"date":147,"type":38},{"date":172,"type":38},"2024-07-01",{"date":174,"type":21},"2026-10-31",{"name":176,"class":45},"The Hong Kong Polytechnic University",{"id":178,"slug":179,"hasResults":11,"nctId":180,"briefTitle":181,"officialTitle":181,"acronym":182,"eligibilityCriteria":183,"healthyVolunteers":11,"sex":16,"minAge":54,"maxAge":111,"enrollmentInfo":184,"targetDuration":4,"studyType":22,"phases":186,"briefSummary":187,"conditions":188,"keywords":4,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":192,"lastUpdatePostDateStruct":193,"startDateStruct":195,"completionDateStruct":197,"leadSponsor":199,"locationsCount":46},"100601634","neuromodulation-enhanced-use-of-robotic-balance-training-to-improve-balance-function-in-individuals-with-stroke-100601634","NCT07113041","Neuromodulation-Enhanced Use of RObotic BALANCE Training to Improve Balance Function in Individuals With Stroke","NEUROBALANCE","Inclusion Criteria:\n\n1. Aged between 18-75 years\n2. Diagnosed with a cortical\u002Fsubcortical ischemic stroke at least 6 months before the screening, as confirmed by the neurological exam or an MRI.\n3. Have complaints of impaired balance and poor postural control determined by a BBS score of ≤50.\n4. Ability to stand upright with or without support for at least 20 seconds\n5. Ability to walk with or without a walking aid for at least ten meters\n6. Not planning to change medication in the next four months\n7. Minimum Cognitive Ability to understand the verbal instructions and comply with the study procedures, as determined by the University of California, San Diego, Brief Assessment of Capacity to Consent Instrument (UBACC).\n\nExclusion Criteria:\n\n1. Currently undergoing any regular physical therapy program or research studies focusing on balance functions.\n2. Having a brainstem stroke.\n3. Contraindication for MRI scan (presence of metal implants, claustrophobia)\n4. Affected by the peripheral nerve injury, neuromuscular conditions, or orthopedic issues of lower limbs before stroke, or have any persistent pain or difficulty maintaining blood pressure while upright.\n5. Have a scalp or skin condition (e.g., psoriasis or eczema) \\* on the scalp near the stimulation site\n6. Having severe visual impairment (e.g., spatial neglect) or hearing problems that may affect study compliance\n7. Any other neurological injury or psychiatric conditions (e.g., severe anxiety or schizophrenia etc.)\n8. Contraindications to MRI, including the presence of non-titanium metallic implants, claustrophobia, etc.\n9. Not be pregnant or thinking of becoming pregnant\n10. Diagnosed with alcohol or substance abuse in the last 3 years\n11. Contraindications to TMS, including the presence of metallic implants in the head and a history of seizures or medication-resistant epilepsy or ongoing use of anti-seizure\u002Fseizure threshold-lowering medications.",{"count":185,"type":21},45,[24],"Our proposed study, \"NEUROBALANCE Stroke,\"; aims to evaluate the effectiveness of a combined intervention involving robotic balance training and noninvasive brain stimulation in improving balance function and postural control in individuals with chronic stroke. The study will recruit 45 participants who have had a stroke at least 6 months before enrolment and experience persistent balance and gait deficits. Participants will be randomized into three groups: (1) robotic balance training with active brain stimulation, (2) robotic balance training with sham brain stimulation, and (3) standard-of-care rehabilitation.\n\nThe study will involve 15 training sessions over 5 weeks, with assessments conducted at baseline, post-training, and two months post-training to evaluate balance recovery and retention. The primary focus is understanding how this intervention affects brain and muscle activity during balance tasks and how these changes translate into functional improvements in clinical outcome measures of balance function. Additionally, participant feedback on brain stimulation and exercise engagement will be collected to inform future studies.\n\nThe findings may guide the development of personalized training protocols and contribute to broader rehabilitation strategies.",[29,189,190,28,191],"Stroke (CVA) or Transient Ischemic Attack","Stroke Ischemic","Balance Deficits","2025-08-01",{"date":194,"type":38},"2025-08-08",{"date":196,"type":38},"2025-06-01",{"date":198,"type":21},"2029-08-31",{"name":200,"class":45},"Kessler Foundation",{"id":202,"slug":203,"hasResults":11,"nctId":204,"briefTitle":205,"officialTitle":206,"acronym":4,"eligibilityCriteria":207,"healthyVolunteers":11,"sex":16,"minAge":159,"maxAge":208,"enrollmentInfo":209,"targetDuration":4,"studyType":22,"phases":211,"briefSummary":212,"conditions":213,"keywords":214,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":217,"lastUpdatePostDateStruct":218,"startDateStruct":220,"completionDateStruct":222,"leadSponsor":224,"locationsCount":46},"100596035","effects-on-subacute-stroke-with-robotic-assistive-gait-training-100596035","NCT07040215","Effects on Subacute Stroke With Robotic Assistive Gait Training","The Effectiveness of Subacute Stroke Patients Receiving Robotic Assisted Gait Training","Inclusion Criteria:\n\n* Diagnosed with stroke (ischemic or hemorrhagic) confirmed by medical imaging.\n* Subacute phase of stroke (onset within 1 to 3 months).\n* Moderate to good standing balance ability.\n* Sufficient cognitive ability to understand the study and follow instructions.\n* Able to participate in rehabilitation training during the study period.\n\nExclusion Criteria:\n\n* Body weight over 90 kg.\n* Presence of other neurological disorders.\n* Severe cardiovascular disease or other health conditions affecting mobility.\n* Significant lower limb pain, joint contracture, or spasticity (Modified Ashworth Scale score \\> 3) that impairs walking.\n* Diagnosed with cardiopulmonary disease that contraindicates exercise training.\n* Cognitive impairment that prevents understanding of training instructions or completion of questionnaires.\n* Inability to complete the rehabilitation training protocol.","70 Years",{"count":210,"type":21},40,[24],"The goal of this randomized controlled trial is to learn about the effects of Robotic Assisted Gait Training (RAGT) combined with traditional physical therapy in subacute stroke patients. The main question it aims to answer is:\n\n\\- Does RAGT combined with traditional physical therapy improve gait and functional performance in subacute stroke patients compared to traditional physical therapy alone? Participants who are subacute stroke patients will be randomly assigned to receive either both RAGT and traditional physical therapy or only traditional physical therapy. Their gait and functional performance will be assessed during the study period.",[29,28],[215,216],"physiotherapy","Robotic Assistive Gait Training","2025-06-26",{"date":219,"type":38},"2025-06-27",{"date":221,"type":21},"2025-07-01",{"date":223,"type":21},"2026-04-30",{"name":225,"class":45},"Changhua Christian Hospital",{"id":227,"slug":228,"hasResults":11,"nctId":229,"briefTitle":230,"officialTitle":230,"acronym":4,"eligibilityCriteria":231,"healthyVolunteers":11,"sex":16,"minAge":232,"maxAge":18,"enrollmentInfo":233,"targetDuration":4,"studyType":22,"phases":235,"briefSummary":236,"conditions":237,"keywords":238,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":241,"lastUpdatePostDateStruct":242,"startDateStruct":244,"completionDateStruct":246,"leadSponsor":248,"locationsCount":46},"100566336","the-effect-of-cupping-on-spasticity-and-function-of-the-lower-extremity-during-rehabilitation-after-stroke-100566336","NCT06653855","The Effect of Cupping on Spasticity and Function of the Lower Extremity During Rehabilitation After Stroke","Inclusion Criteria:\n\n* Age 30-80\n* Acute stroke (within 6 months of stroke), with spasticity \\& hemiparesis of LE\n* Referred by doctor for rehabilitation for a stroke-related condition\n* Attending Ascension Rehabilitation of Joliet for rehabilitation\n* Able to read or verbally understand English or Spanish\n\nExclusion Criteria:\n\n* Absent sensation of the areas to be cupped\n* Significant cognitive impairment\n* Pregnancy\n* Prescription anticoagulant medications\n* Blood clotting disorder\n* Uncontrolled hypertension\n* Uncontrolled diabetes\n* Open wounds within the cupping area\n* Current DVT\n* Hematoma over the cupping area\n* Fracture over the cupping area\n* Active cancer within the cupping area\n* Current use of Baclofen\n* Current use of Botox\n* Current use of an anti-spasticity medication","30 Years",{"count":234,"type":21},30,[24],"Physical therapists use dry static cupping for the treatment of many conditions, including spasticity for patients post-stroke. While research better describes the effects of dry static cupping for patients with orthopedic conditions, information is lacking on central conditions, such as stroke and resulting spasticity.",[28],[239,240,91,168],"Cupping","Spasticity","2024-12-10",{"date":243,"type":38},"2024-12-13",{"date":245,"type":21},"2024-12",{"date":247,"type":21},"2026-01",{"name":249,"class":250},"Scott Getsoian","INDUSTRY"]